Plenary Speakers

THE 2020 PLENARY SPEAKERS ARE:

Jesse Cedarbaum, USA

Coeruleus Clinical Sciences | 16 Old Barnabas Rd, Woodbridge, CT 06525, USA

DIGITAL TECHNOLOGIES, BRIGHT SHINY OBJECTS AND THE FUTURE OF CLINICAL TRIALS IN PARKINSON’S DISEASE

Jeff Cummings, USA

University of Nevada Las Vegas (UNLV) School of Allied Health Sciences and Cleveland Clinic Lou Ruvo Center for Brain Health

ALZHEIMER’S DRUG DEVELOPMENT PIPELINE:  NOVEL TARGETS AND INNOVATIVE APPROACHES

Miia Kivipelto, Sweden

Senior Geriatrician, Director of Research, Development, Education and Innovation Karolinska University Hospital |Theme Aging, Karolinska Institute | Dept NVS | Division of Clinical Geriatrics | Center for Alzheimer Research

WORLD-WIDE FINGERS AND THE NEXT GENERATION OF CLINICAL TRIALS IN ALZHEIMER´S DISEASE

Samantha Budd-Haeberlein, USA

Vice President, Head Late Stage Clinical Development Alzheimer’s disease, Dementia & Movement Disorders at Biogen

ADUCANUMAB PHASE 3 PROGRAM TOPLINE RESULTS

Julie Schneider, USA

The Deborah R. And Edgar D. Jannotta Presidential Professor of Pathology and Neurological Sciences Associate Director, Rush Alzheimer’s Disease Center, Rush University Medical Center

THE CONTRIBUTION OF TDP43 TO COGNITIVE DISORDERS OF LATE LIFE